How Much Do You Really Know About Typhoid Fever and Cholera?

Complete our short quiz and get our free Travelers' Companion brochure!

First Name *

Last Name *

Email *

Travelers' Companion:

A guide to helping you stay healthy on your journey

You’re planning a trip outside the United States. So, of course you’re excited...and you’re not alone. More and more people like you are traveling internationally. With so many people traveling, more people are being exposed to diseases that may not be present in the US. One way to protect yourself and your family is to get vaccinated against diseases you might encounter while traveling abroad. However, there may not be vaccines available to protect you against every disease you could contract in the countries you are visiting. This guide will do the following:

Describe steps you can take to help protect yourself against getting sick in other countries
Provide you with helpful tips to ensure a safe and healthy travel experience

You’ll want to bring home souvenirs, a smartphone full of photos and videos, and fantastic memories—NOT an illness.

Our vision

Protecting and Enhancing 50 million lives by 2025 focuses our energy to improve the quality of life for millions of individuals around the world, giving them the opportunity to experience the fullness of life.

Our drive towards this vision informs all of our actions—whether it is our approach to product development, manufacturing, encouraging employee health and wellness or giving back to the community—we strive every day to achieve this shared goal.

Innovation

Unlocking our full potential. Powering our mindset.
Advancing our mission.

Innovation by employees at all levels is the key to achieving our full potential as individuals and as an organization. We embrace the mindset that we are never done, never satisfied, never standing still. Innovation is the call to go higher, faster and farther in our mission to protect and enhance life.

Vaxchora Indications and Usage

Vaxchora® (Cholera Vaccine, Live, Oral) is a vaccine indicated for active immunization against disease caused by Vibrio cholerae serogroup O1 in adults 18 through 64 years of age traveling to cholera-affected areas. Limitations of Use: The effectiveness of Vaxchora has not been established in persons living in cholera-affected areas. The effectiveness of Vaxchora has not been established in persons who have pre-existing immunity due to previous exposure to V. cholerae or receipt of a cholera vaccine. Vaxchora has not been shown to protect against disease caused by V. cholerae serogroup O139 or other non-O1 serogroups.

Vaxchora Important Safety Information

Vaxchora Limitations of Use: The effectiveness of Vaxchora has not been established in persons living in cholera-affected areas. The effectiveness of Vaxchora has not been established in persons who have pre-existing immunity due to previous exposure to V. cholerae or receipt of a cholera vaccine. Vaxchora has not been shown to protect against disease caused by V. cholerae serogroup O139 or other non-O1 serogroups.

Please see full Prescribing Information

Vivotif Indications and Usage

Vivotif (Typhoid Vaccine Live Oral Ty21a) is indicated for immunization of adults and children greater than 6 years of age against disease caused by Salmonella Typhi. Routine typhoid vaccination is not recommended in the United States of America. Selective immunization against typhoid fever is recommended for the following groups: 1) travelers to areas in which there is a recognized risk of exposure to S. Typhi; 2) persons with intimate exposure (eg, household contact) to an S. Typhi carrier; and 3) microbiology laboratorians who work frequently with S. Typhi. There is no evidence to support the use of typhoid vaccine to control common source outbreaks, disease following natural disasters, or in persons attending rural summer camps. Not all recipients of Vivotif will be fully protected against typhoid fever. Vaccinated individuals should continue to take personal precautions against exposure to typhoid organisms. The vaccine will not afford protection against species of Salmonella other than Salmonella Typhi or other bacteria that cause enteric disease. The vaccine is not suitable for treatment of acute infections with S. Typhi.

Vivotif Important Safety Information

Vivotif (Typhoid Vaccine Live Oral Ty21a) should not be administered to persons with a hypersensitivity to any component of the vaccine or the enteric-coated capsule. The vaccine should not be administered to persons during an acute febrile illness. Safety of the vaccine has not been demonstrated in persons deficient in their ability to mount a humoral or cell-mediated immune response, due to either a congenital or acquired immunodeficient state including treatment with immunosuppressive or antimitotic drugs. The vaccine should not be administered to these persons regardless of benefits.

Vivotif is not to be taken during an acute gastrointestinal illness. The vaccine should not be administered to individuals receiving sulfonamides and antibiotics since these agents may be active against the vaccine strain and prevent a sufficient degree of multiplication to occur in order to induce a protective immune response. Postpone taking the vaccine if persistent diarrhea or vomiting is occurring. Unless a complete immunization schedule is followed, an optimum immune response may not be achieved. Not all recipients of Vivotif will be fully protected against typhoid fever. Vaccinated individuals should continue to take personal precautions against exposure to typhoid organisms, ie, travelers should take all necessary precautions to avoid contact or ingestion of potentially contaminated food or water.

The health care professional should take all necessary precautions to ensure safe and effective use of the vaccine. Patients should be questioned about previous reactions to this or similar products. The previous immunization history of the patient and current antibiotic usage should be obtained by the health care professional.